Cancer and Rare Disease Drugs to Become More Affordable in 2026
A significant development in healthcare affordability is on the horizon! The Union Budget 2026 brings good news for patients battling cancer and rare diseases, as 24 essential medications will become more affordable.
Upstox Securities Pvt. Ltd., a trusted financial entity, provides the following information:
- SEBI Registration: INZ000315837
- NSE TM Code: 13942
- BSE TM Code: 6155
- CDSL Reg No.: IN-DP-761-2024
- CIN: U65100DL2021PTC376860
- Compliance Officer: Mr. Kapil Jaikalyani (Tel: (022) 24229920, Email: compliance@upstox.com)
- Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001
RKSV Commodities India Pvt. Ltd., an associate company, has the following details:
- SEBI Registration: INZ000015837
- MCX TM Code: 46510
- CIN: U74900DL2009PTC189166
- Compliance Officer: Mr. Amit Lalan (Tel: (022) 24229920, Email: compliance@rksv.in)
- Registered Address: 807, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001
- Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai - 400013
For any concerns, contact:
Email: complaints@upstox.com and complaints.mcx@upstox.com
SEBI SCORES Complaint Procedure:
Register on SCORES, providing Name, PAN, Address, Mobile, and Email. This ensures efficient grievance resolution. Review the SEBI Risk Disclosure Document, Terms of Use, and Privacy Policy for informed decision-making.
Upstox Securities Private Limited is a subsidiary of RKSV Securities India Private Limited, and RKSV Commodities India Private Limited is an associate company.
Disclaimer: Investing in securities carries market risks. Always read relevant documents before investing.
Derivatives Risk Disclosure:
- 90% of individual equity traders in Futures and Options experienced net losses.
- Average losses reached approximately ₹50,000.
- Loss-making traders spent an extra 28% of their losses on transaction costs.
- Traders with profits incurred 15-50% of those profits as transaction costs.
Mutual Funds: Top-rated funds are not recommendations. Data is provided by Morningstar. Read offer documents before investing. Upstox is not liable for investment outcomes.
These products are not exchange-traded, and the member acts as a distributor. Disputes related to distribution are outside the Exchange's investor redressal or arbitration processes.
Investor Alerts:
- Avoid unauthorized collective investments and schemes promising fixed returns (as per NSE, BSE, and MCX circulars dated July 6 and July 11, 2022).
- Do not share login credentials, trading strategies, or position details.
- Understand leveraged products and derivatives like Options to avoid losses.
- Avoid trading options without product knowledge.
- Ignore unsolicited tips from social media or messaging platforms.
- Do not trade based on unauthorized advisor recommendations.
Important Guidelines:
- Read the Investor Advisory Guidelines (https://bit.ly/3jwnuwA) for awareness and asset protection.
- Update KYC details by March 31, 2022 (https://uptx.to/KYC-Updation).
Secure Your Accounts:
- Update mobile numbers with your depository participant to prevent unauthorized Demat transactions.
- Receive alerts for debit and transactions directly from CDSL.
- Update contact details with stockbrokers to secure Trading accounts.
- Get transaction information from the Exchange daily.
IPO Subscription: Investors no longer need to issue cheques. Authorize payments via bank account details and signatures. Refunds are secure. As of September 1, 2020, stockbrokers must accept securities as margin through the depository system.
Stay Informed:
- Update contact details with stockbrokers/depository participants.
- Receive OTPs directly from the depository for pledge creation.
- Review your investments monthly in the NSDL/CDSL Consolidated Account Statement (CAS).
SEBI ODR Portal:
SEBI's Online Dispute Resolution Portal offers efficient dispute resolution for investors and listed companies. Visit https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the-indian-securities-market_74794.html for more information. ODR portal: https://smartodr.in/login
And here's a thought: Are we doing enough to make healthcare accessible to all? Share your views in the comments below!
